Trials / Completed
CompletedNCT06351761
WIBOFA - Validation of SCT02 With ECG-App for Detection of AF
Validation of Withings BeamO With Withings ECG-App for the Detection of Atrial Fibrillation
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 373 (actual)
- Sponsor
- Withings · Industry
- Sex
- All
- Age
- 22 Years
- Healthy volunteers
- Accepted
Summary
The aim of the study is to evaluate the performance of Withings SCT02 with embedded Withings ECG-app in the automatic detection of atrial fibrillation
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Investigational Device (Withings SCT02) 30 second Electrocardiogram recording | 30 second ECG recording with investigational device (Withings SCT02) |
| DEVICE | Reference Device (Schiller Cardiovit FT-1) 30 second Electrocardiogram recording | 30 second ECG recording with reference device (Schiller Cardiovit FT-1) |
Timeline
- Start date
- 2024-06-03
- Primary completion
- 2025-06-10
- Completion
- 2025-11-26
- First posted
- 2024-04-08
- Last updated
- 2026-02-18
Locations
4 sites across 2 countries: United States, France
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06351761. Inclusion in this directory is not an endorsement.